MolNFT v1 · #173576 · protein + DNA
Structural basis of reactivation of oncogenic P53 mutants by a small molecule: methylene quinuclidinone (mq). human wild-type P53DBD bound to DNA and mq: wt-DNA-mq (P1)
7B46: “Structural basis of reactivation of oncogenic P53 mutants by a small molecule: methylene quinuclidinone (mq).…”. X-ray diffraction, 3 ligands (QN8, QNN, ZN). MolNFT v1 #173576 on GenesisL1: 3D structure, binding sites and pockets in…
- PDB
- 7B46
- Type
- protein + DNA
- Length
- 809 residues
- Chains
- 8
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P04637
- Ligands
- QN8, QNN, ZN
Structure
x-ray diffraction · 6 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 192 | — | P04637 |
| B | — | protein | 191 | — | P04637 |
| C | — | protein | 190 | — | P04637 |
| D | — | protein | 192 | — | P04637 |
| E, H | — | dna | 11 | — | — |
| F, G | — | dna | 11 | — | — |
Ligands and binding sites
- QN8 · (2~{R})-2-methyl-1-azabicyclo[2.2.2]octan-3-one · ligand · 7 copies · chains A, E, F, B, C, G, H, D
- QNN · (2~{S})-2-methyl-1-azabicyclo[2.2.2]octan-3-one · ligand · chains D
- ZN · Zinc ion · metal · 4 copies · chains A, B, C, D
- ACT · Acetate ion · additive · chains B, C
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7B46 · Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene… · the same entry in another collection · chain H against H, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P04637
- Elsewhere: RCSB PDB 7B46 · PDBe 7B46 · UniProt P04637
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.